99 related articles for article (PubMed ID: 4697954)
41. Tay-Sachs disease and carrier screening programs: psychosocial aspects.
Schneiderman G; Lowden JA; Rae-grant Q
Can J Public Health; 1977; 68(1):66-8. PubMed ID: 849576
[No Abstract] [Full Text] [Related]
42. Regionalization of a birth defects prevention clinic.
Acker D; Richman D
Am J Obstet Gynecol; 1976 Aug; 125(7):933-6. PubMed ID: 941947
[TBL] [Abstract][Full Text] [Related]
43. Letter: Screening for Tay-Sachs disease.
Evans PR; Ellis RB
Lancet; 1974 Mar; 1(7857):575-6. PubMed ID: 4132029
[No Abstract] [Full Text] [Related]
44. Letter: Screening for carriers of Tay-Sachs disease.
Jackson LG; Glazerman LR; Faust HS; Nimoityn P
JAMA; 1974 Aug; 229(6):640. PubMed ID: 4408282
[No Abstract] [Full Text] [Related]
45. The National Tay-Sachs and Allied Diseases Association, Inc.
Saperstein J
Prog Clin Biol Res; 1977; 18():9-10. PubMed ID: 601099
[No Abstract] [Full Text] [Related]
46. Knowledge and attitudes toward Tay-Sachs disease among a college student population.
Austein CF; Seashore MR; Mick SS
Yale J Biol Med; 1981; 54(5):345-54. PubMed ID: 7336765
[TBL] [Abstract][Full Text] [Related]
47. Some influences on public participation in a genetic screening program.
Becker MH; Kaback MM; Rosenstock IM; Ruth MV
J Community Health; 1975; 1(1):3-14. PubMed ID: 1228204
[TBL] [Abstract][Full Text] [Related]
48. [Clinical, biochemical and ultrastructural study of a case of Tay-Sachs disease with hexosaminidase deficiency].
Fontaine G; Maillard E; Farriaux JP; Strecker G; Montreuil J; Resibois A; Tondeur M; Jonniaux G; Loeb H
Arch Fr Pediatr; 1970 Apr; 27(4):447-8. PubMed ID: 5421719
[No Abstract] [Full Text] [Related]
49. Separation of N-acetyl- -D-hexosaminamidase-isoenzymes from human brain and leukocytes by cellulose acetate paper electrophoresis: a simple procedure for the diagnosis of Tay-Sachs disease.
Klibansky C
Isr J Med Sci; 1971 Sep; 7(9):1086-9. PubMed ID: 5151274
[No Abstract] [Full Text] [Related]
50. Diagnosis of Tay-Sachs disease by hexosaminidase activity in leukocytes and amniotic fluid cells.
Padeh B; Navon R
Isr J Med Sci; 1971 Feb; 7(2):259-63. PubMed ID: 5560980
[No Abstract] [Full Text] [Related]
51. Mass screening for Tay-Sachs.
Hastings Cent Rep; 1983 Jun; 13(3):44-5. PubMed ID: 6885402
[No Abstract] [Full Text] [Related]
52. Letter: Demographic data as graphic aid in screening program for Tay-Sachs disease.
Gardner LI; Meltzer SL
J Pediatr; 1975 Oct; 87(4):664-5. PubMed ID: 1159604
[No Abstract] [Full Text] [Related]
53. Cozening the people--a reply from the Tay-Sachs Association.
N Engl J Med; 1977 Nov; 297(19):1071-2. PubMed ID: 909561
[No Abstract] [Full Text] [Related]
54. Lipidomics in diagnosis of lipidoses.
Wolf C; Quinn PJ
Subcell Biochem; 2008; 49():567-88. PubMed ID: 18751927
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis of Tay-Sachs.
O'Brien JS
Nature; 1969 Dec; 224(5223):1038. PubMed ID: 5360546
[No Abstract] [Full Text] [Related]
56. Tay-Sachs screening clinic.
Gitelman BJ; Sears EV; Partington MW
Can Med Assoc J; 1981 Oct; 125(8):814, 816. PubMed ID: 7306889
[No Abstract] [Full Text] [Related]
57. The fine structure of fetal Tay-Sachs disease.
Adachi M; Torii J; Schneck L; Volk BW
Arch Pathol; 1971 Jan; 91(1):48-54. PubMed ID: 4922628
[No Abstract] [Full Text] [Related]
58. Letter: Use of demographic data in screening for Tay-Sachs disease.
Nimoityn P; Faust HS; Glazerman LR; Jackson LG
J Pediatr; 1976 Jul; 89(1):162. PubMed ID: 932893
[No Abstract] [Full Text] [Related]
59. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
Zlotogora J; Leventhal A
Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
[TBL] [Abstract][Full Text] [Related]
60. Prenatal screening for Tay-Sachs disease by Louisiana obstetricians: a survey study.
Hill LW; Schorr SJ
South Med J; 2001 Sep; 94(9):910-2. PubMed ID: 11592753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
